Compare · BLCO vs LUCY
BLCO vs LUCY
Side-by-side comparison of Bausch + Lomb Corporation (BLCO) and Innovative Eyewear Inc. (LUCY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLCO and LUCY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- BLCO is the larger of the two at $5.51B, about 948.1x LUCY ($5.8M).
- Over the past year, BLCO is up 29.4% and LUCY is down 67.2% - BLCO leads by 96.6 points.
- BLCO has hit the wire 16 times in the past 4 weeks while LUCY has been quiet.
- BLCO has more recent analyst coverage (18 ratings vs 0 for LUCY).
- Company
- Bausch + Lomb Corporation
- Innovative Eyewear Inc.
- Price
- $15.48+0.72%
- $0.91-5.40%
- Market cap
- $5.51B
- $5.8M
- 1M return
- -3.25%
- -14.29%
- 1Y return
- +29.43%
- -67.17%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- 2022
- News (4w)
- 16
- 0
- Recent ratings
- 18
- 0
Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions. It offers intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Latest BLCO
- SEC Form SD filed by Bausch + Lomb Corporation
- Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
- Director Von Eschenbach Andrew C. was granted 15,842 shares, increasing direct ownership by 22% to 86,656 units (SEC Form 4)
- Director Ross Thomas W. Sr. was granted 15,842 shares, increasing direct ownership by 23% to 85,233 units (SEC Form 4)
- Director Robertson Russel C was granted 15,842 shares, increasing direct ownership by 20% to 94,260 units (SEC Form 4)
- Director Paulson John was granted 15,842 shares, increasing direct ownership by 21% to 89,823 units (SEC Form 4)
- Director Ling Karen was granted 15,842 shares, increasing direct ownership by 35% to 61,518 units (SEC Form 4)
- Director Kavanagh Sarah B was granted 15,842 shares, increasing direct ownership by 30% to 69,541 units (SEC Form 4)
- Director Collis Steven H was granted 15,842 shares, increasing direct ownership by 61% to 42,003 units (SEC Form 4)
- Director Bernier Nathalie D. was granted 15,842 shares, increasing direct ownership by 23% to 85,505 units (SEC Form 4)
Latest LUCY
- Innovative Eyewear Inc. Reports Q1 2026 Unaudited Financial Results
- SEC Form 10-Q filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Announces Real-Time AI Translated Calls for the Lucyd App
- Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Announces Preliminary Q1 2026 Results
- Innovative Eyewear, Inc. Receives Red Dot Design Award on Lucyd Armor Smart Safety Glasses
- Innovative Eyewear, Inc. Announces New Reebok Optical Collection and Retail Placements
- Innovative Eyewear, Inc. Announces New Smart Safety Glasses and Rx Safety Partner
- Innovative Eyewear Inc. Reports Full Year 2025 Financial Results
- SEC Form 10-K filed by Innovative Eyewear Inc.